Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Receptor agonist therapy offers targeted action, predictable dose responses, and potential reduction of adverse effects
Note on humans: These benefits are not established in humans , and the blend has not been studied in controlled human trials
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
570 TlleMFreitagHAntelmannMHartwigJSchuchardtMvan der Giet,Met al
Skipping your next dose to compensate creates a 14-day gap, which will cause your blood levels to drop below therapeutic range
2 However, the total amount absorbed was unchanged
US$ 23.56
US$ 21.74
US$ 27.48
US$ 22.78
US$ 24.03
US$ 20.16
US$ 24.85
US$ 21.01
